Search Results

You are looking at 71 - 80 of 899 items for :

  • "metastases" x
  • Refine by Access: All x
Clear All
Full access

Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines

Angela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, Marina Deuker, Franciska Stolzenbach, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Anil Kapoor, Cristian Fiori, Francesco Porpiglia, and Pierre I. Karakiewicz

better elucidate the distribution of age, sex, histologic subtype, and FG, in addition to assessing the rates of synchronous metastases in a large contemporary population-based cohort. We hypothesized that most patients harbored FG1–2 tumors, either the

Full access

Agreement in Metastatic Spinal Cord Compression

Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Úrsula Pérez-Ramírez, Javier Zamora, and the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis

Background Malignant or metastatic spinal cord compression of the thecal sac is a devastating medical emergency presented by 5% to 20% of patients with spinal metastases. 1 It can be caused by vertebral collapse, but is usually provoked by

Full access

Routine Use of Zoledronic Acid in Early-Stage Breast Cancer

Kathleen Harnden and Kimberly Blackwell

Bisphosphonates are an integral part of treatment for bone metastases in many malignancies, including breast cancer. Bone metastases can have devastating consequences, including severe pain, fractures, hypercalcemia, and spinal cord compression

Full access

Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer

Wen-Zhuo He, Wan-Ming Hu, Fang Wang, Yu-Ming Rong, Lin Yang, Qian-Kun Xie, Yuan-Zhong Yang, Chang Jiang, Hui-Juan Qiu, Jia-Bin Lu, Bei Zhang, Pei-Rong Ding, Xiao-Jun Xia, Jian-Yong Shao, and Liang-Ping Xia

, particularly genetic discordances between the primary and the metastatic sites. 3 – 6 Moreover, oxidative DNA damage and some chemokines were significantly higher in metastases than in primary tumors, 7 , 8 and the level of tumor-infiltrating lymphocytes and

Full access

Thymomas and Thymic Carcinomas

David S. Ettinger, Gregory J. Riely, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D’Amico, Todd L. Demmy, Ramaswamy Govindan, Frederic W. Grannis Jr, Stefan C. Grant, Leora Horn, Thierry M. Jahan, Ritsuko Komaki, Feng-Ming (Spring) Kong, Mark G. Kris, Lee M. Krug, Rudy P. Lackner, Inga T. Lennes, Billy W. Loo Jr, Renato Martins, Gregory A. Otterson, Jyoti D. Patel, Mary C. Pinder-Schenck, Katherine M. Pisters, Karen Reckamp, Eric Rohren, Theresa A. Shapiro, Scott J. Swanson, Kurt Tauer, Douglas E. Wood, Stephen C. Yang, Kristina Gregory, and Miranda Hughes

, treatment, and management of these mediastinal tumors. Mediastinal Masses Masses in the anterior mediastinum can be neoplasms (eg, thymomas, lymphomas, thymic carcinomas, thymic carcinoids, thymolipomas, germ cell tumors, lung metastases) or

Full access

Central Nervous System Cancers

Louis Burt Nabors, Mario Ammirati, Philip J. Bierman, Henry Brem, Nicholas Butowski, Marc C. Chamberlain, Lisa M. DeAngelis, Robert A. Fenstermaker, Allan Friedman, Mark R. Gilbert, Deneen Hesser, Matthias Holdhoff, Larry Junck, Ronald Lawson, Jay S. Loeffler, Moshe H. Maor, Paul L. Moots, Tara Morrison, Maciej M. Mrugala, Herbert B. Newton, Jana Portnow, Jeffrey J. Raizer, Lawrence Recht, Dennis C. Shrieve, Allen K. Sills Jr, David Tran, Nam Tran, Frank D. Vrionis, Patrick Y. Wen, Nicole McMillian, and Maria Ho

patients with systemic cancer will develop brain metastases. 3 Principles of Management Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. Primary brain tumors range from

Full access

National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non–Small Cell Lung Cancer

Stephen R. Grant, Benjamin D. Smith, Lauren E. Colbert, Qunyh-Nhu Nguyen, James B. Yu, Steven H. Lin, and Aileen B. Chen

Background Bone metastases are common in patients presenting with metastatic non–small cell lung cancer (NSCLC) and are often treated with palliative radiation therapy. 1 There exists wide practice variability in palliative treatment

Full access

Early Application of Next-Generation Sequencing Identifies Pancreatic Mass as Metastasis From an EGFR-Mutated Lung Adenocarcinoma

Luxi Chen, John Davelaar, Srinivas Gaddam, Kambiz Kosari, Nicholas Nissen, George Chaux, Christopher Lee, Eric Vail, Andrew Hendifar, Jun Gong, Karen Reckamp, and Arsen Osipov

metastases from lung primaries account for approximately 9% to 14.7% of all pancreatic metastases, representing <0.3% of all pancreatic malignancies. 6 , 7 Pancreatic secondaries are rarely diagnosed simultaneously with the primary tumor because they are

Full access

Surgery for Gastrinoma and Insulinoma in Multiple Endocrine Neoplasia Type 1

Jeffrey A. Norton, Tony D. Fang, and Robert T. Jensen

arterial chemoembolization in the management of advanced digestive endocrine tumors . Digestion 2000 ; 62 : 79 – 83 . 25. Ruszniewski P Rougier P Roche A . Hepatic arterial chemoembolization in patients with liver metastases of endocrine

Full access

Update on the Sentinel Node Procedure in Vulvar Cancer

Willemijn L. van der Kolk, Joost Bart, Ate J.G. van der Zee, and Maaike H.M. Oonk

diagnostic purposes and determining further treatment. With this procedure, the first tumor-draining lymph nodes are identified, removed, and examined for metastases. Before the introduction of the SN procedure, inguinofemoral lymphadenectomy (IFL) was